Ami Fadia
Stock Analyst at Needham
(0.84)
# 2105
Out of 5,329 analysts
474
Total ratings
34.36%
Success rate
-5.50%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SAGE Sage Therapeutics | Reiterates: Hold | n/a | n/a | n/a | 21 | Apr 30, 2025 | |
BPMC Blueprint Medicines | Maintains: Buy | 133 130 | 99.27 | 30.96% | 30 | Apr 28, 2025 | |
BIIB Biogen | Reiterates: Hold | n/a | n/a | n/a | 39 | Apr 25, 2025 | |
NBIX Neurocrine Bioscienc... | Upgrades: Buy | 138 | 106.71 | 29.32% | 13 | Apr 15, 2025 | |
JAZZ Jazz Pharmaceuticals | Reiterates: Buy | 210 210 | 117.19 | 79.2% | 29 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 50 50 | 29.9 | 67.22% | 35 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.28 | 837.5% | 15 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.77 | 549.35% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 9.07 | 230.76% | 19 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 19 19 | 8.62 | 120.42% | 35 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 83 83 | 45.4 | 82.82% | 27 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 59 59 | 40.69 | 45% | 22 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 28 | 14.59 | 91.91% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 38.16 | 122.75% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 153 153 | 112.47 | 36.04% | 14 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 32 | 7.63 | 319.4% | 19 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 27 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 6 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 7 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | n/a | n/a | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 28 26 | n/a | n/a | 6 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 240 320 | 10.99 | 2811.74% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 63 75 | 26.78 | 180.06% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 5 | n/a | n/a | 2 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 10 14 | n/a | n/a | 3 | Oct 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 15 23 | 1.08 | 1983.33% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 64 63 | 25.29 | 149.11% | 4 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 2 | n/a | n/a | 8 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 10 | n/a | n/a | 2 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 24 | n/a | n/a | 8 | Jan 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 20 | n/a | n/a | 2 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 5 | 2.54 | 96.85% | 2 | Jan 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | n/a | n/a | n/a | 7 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | n/a | n/a | 5 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 2.34 | 840.17% | 4 | Jan 3, 2018 |